Contract award · W81XWH20C0105
AWARD OF RXFUNCTION'S DHA SBIR PHASE II MEDICAL R&D CONTRACT FOR "OPTIMIZE PERFORMANCE AND MITIGATE FALLS IN WARFIGHTERS WITH LOWER LIMB TRAUMA AND/OR LOSS"
Awarded to RXFUNCTION, INC. · CAGE 62V99
Latest reported total obligated
Not reported
Net observed obligations
$1.1M
Observed contract actions
3
Observed period
FY2020–FY2023
Reported totals are cumulative values from the latest available award record. Observed obligations and actions reflect Mimir's FY2019 onward transaction window and may omit earlier activity.
Award parties and scope
ContractorRXFUNCTION, INC.
CAGE62V99
CustomerDepartment of the Army
Performance locationEDEN PRAIRIE, MINNESOTA, UNITED STATES
Procurement details
First observed actionAug 26, 2020
Latest observed actionAug 28, 2023
PSCAN91
NAICS541715 · Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
CompetitionFULL AND OPEN COMPETITION AFTER EXCLUSION OF SOURCES
PricingFIRM FIXED PRICE
SolicitationHQ003420R1DSB
Annual observed obligations
FY2020
$1.1M
Continue exploring
Ask Mimir about W81XWH20C0105
Continue with this contract award already in context.
ContinueExplore the full award in Mimir
Open the complete action history and connected analysis in the platform.